APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Blood Proteomics Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Blood Proteomics Services Market Analysis and Forecast 2026-2032

Report ID 174469780512 August 2026192 pages

Choose your research edition.

Industry ResearchBlood Proteomics Services Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Proteomics Services Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Blood Proteomics Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Proteomics Services Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Proteomics Services Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Blood Proteomics Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Blood Proteomics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Blood Proteomics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Blood Proteomics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Blood Proteomics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Blood Proteomics Services include BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, Cell Signaling Technology (CST) and Sampled (Infinity Biologix), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Blood Proteomics Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Blood Proteomics Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Blood Proteomics Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Blood Proteomics Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Blood Proteomics Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Blood Proteomics Services revenue, projected growth trends, production technology, application and end-user industry.

Blood Proteomics Services Segment by Company

BostonGene

CellCarta

GENEWIZ (Azenta Life Sciences)

CDI Labs

Biognosys

Discovery Life Sciences

Firalis Molecular Precision

Cell Signaling Technology (CST)

Sampled (Infinity Biologix)

APTBIO

Sinotech Genomics

Biodesix

Panome Bio

Novogene

PTM BIO

BGI Genomics

Evotec

Metware Biotechnology

MRM Proteomics

Lc-Bio Technologies

Eurofins Scientific

MtoZ-Biolabs

Creative Proteomics

Macrogen

TATAA Biocenter

OmicScouts (Momentum Biotechnologies)

Precision Biomarker Laboratories (PBL)

Shanghai OE Biotech

RxCelerate

Proteomics International

Proteome Sciences

Westlake Omics

Crown Bioscience

VProteomics

Shanghai Majorbio Bio-Pharm

Applied Biomics

Sapient Bioanalytics

Allumiqs

MS Bioworks

Shanghai Bioprofile

Cosmos Wisdom

Olink (Thermo Fisher Scientific)

SomaLogic (Illumina)

Labcorp

Blood Proteomics Services Segment by Type

Blood Proteomics

Blood Modification Proteomics

Olink (Targeted) Proteomics

Blood Proteomics Services Segment by Application

Disease Biomarker Research

Drug Development

Clinical Research

Others

Blood Proteomics Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Proteomics Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Proteomics Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Proteomics Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Blood Proteomics Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Blood Proteomics Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Proteomics Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Blood Proteomics Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Blood Proteomics Major Player Table 3. Blood Modification Proteomics Major Player Table 4. Olink (Targeted) Proteomics Major Player Table 5. Global Blood Proteomics Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Disease Biomarker Research Major Player Table 7. Drug Development Major Player Table 8. Clinical Research Major Player Table 9. Others Major Player Table 10. Blood Proteomics Services Industry Trends Table 11. Blood Proteomics Services Industry Drivers Table 12. Blood Proteomics Services Industry Opportunities and Challenges Table 13. Blood Proteomics Services Industry Restraints Table 14. Global Blood Proteomics Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Blood Proteomics Services Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Blood Proteomics Services Market Share by Region (2021-2026) Table 17. Global Blood Proteomics Services Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Blood Proteomics Services Market Share by Region (2027-2032) Table 19. Global Blood Proteomics Services Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Blood Proteomics Services Revenue Market Share by Players (2021-2026) Table 21. Global Blood Proteomics Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Blood Proteomics Services Key Players Headquarters & Area Served Table 23. Global Blood Proteomics Services Players, Product Type & Application Table 24. Global Blood Proteomics Services Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Blood Proteomics Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Blood Proteomics Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Blood Proteomics Services Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Blood Proteomics Services Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Blood Proteomics Services Revenue Market Share by Type (2021-2026) Table 31. Global Blood Proteomics Services Revenue Market Share by Type (2027-2032) Table 32. Global Blood Proteomics Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Blood Proteomics Services Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Blood Proteomics Services Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Blood Proteomics Services Revenue Market Share by Application (2021-2026) Table 36. Global Blood Proteomics Services Revenue Market Share by Application (2027-2032) Table 37. BostonGene Company Information Table 38. BostonGene Business Overview Table 39. BostonGene Blood Proteomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. BostonGene Blood Proteomics Services Product Portfolio Table 41. BostonGene Recent Development Table 42. CellCarta Company Information Table 43. CellCarta Business Overview Table 44. CellCarta Blood Proteomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. CellCarta Blood Proteomics Services Product Portfolio Table 46. CellCarta Recent Development Table 47. GENEWIZ (Azenta Life Sciences) Company Information Table 48. GENEWIZ (Azenta Life Sciences) Business Overview Table 49. GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Product Portfolio Table 51. GENEWIZ (Azenta Life Sciences) Recent Development Table 52. CDI Labs Company Information Table 53. CDI Labs Business Overview Table 54. CDI Labs Blood Proteomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. CDI Labs Blood Proteomics Services Product Portfolio Table 56. CDI Labs Recent Development Table 57. Biognosys Company Information Table 58. Biognosys Business Overview Table 59. Biognosys Blood Proteomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Biognosys Blood Proteomics Services Product Portfolio Table 61. Biognosys Recent Development Table 62. Discovery Life Sciences Company Information Table 63. Discovery Life Sciences Business Overview Table 64. Discovery Life Sciences Blood Proteomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Discovery Life Sciences Blood Proteomics Services Product Portfolio Table 66. Discovery Life Sciences Recent Development Table 67. Firalis Molecular Precision Company Information Table 68. Firalis Molecular Precision Business Overview Table 69. Firalis Molecular Precision Blood Proteomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Firalis Molecular Precision Blood Proteomics Services Product Portfolio Table 71. Firalis Molecular Precision Recent Development Table 72. Cell Signaling Technology (CST) Company Information Table 73. Cell Signaling Technology (CST) Business Overview Table 74. Cell Signaling Technology (CST) Blood Proteomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Cell Signaling Technology (CST) Blood Proteomics Services Product Portfolio Table 76. Cell Signaling Technology (CST) Recent Development Table 77. Sampled (Infinity Biologix) Company Information Table 78. Sampled (Infinity Biologix) Business Overview Table 79. Sampled (Infinity Biologix) Blood Proteomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Sampled (Infinity Biologix) Blood Proteomics Services Product Portfolio Table 81. Sampled (Infinity Biologix) Recent Development Table 82. APTBIO Company Information Table 83. APTBIO Business Overview Table 84. APTBIO Blood Proteomics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. APTBIO Blood Proteomics Services Product Portfolio Table 86. APTBIO Recent Development Table 87. Sinotech Genomics Company Information Table 88. Sinotech Genomics Business Overview Table 89. Sinotech Genomics Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Sinotech Genomics Blood Proteomics Services Product Portfolio Table 91. Sinotech Genomics Recent Development Table 92. Biodesix Company Information Table 93. Biodesix Business Overview Table 94. Biodesix Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Biodesix Blood Proteomics Services Product Portfolio Table 96. Biodesix Recent Development Table 97. Panome Bio Company Information Table 98. Panome Bio Business Overview Table 99. Panome Bio Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Panome Bio Blood Proteomics Services Product Portfolio Table 101. Panome Bio Recent Development Table 102. Novogene Company Information Table 103. Novogene Business Overview Table 104. Novogene Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Novogene Blood Proteomics Services Product Portfolio Table 106. Novogene Recent Development Table 107. PTM BIO Company Information Table 108. PTM BIO Business Overview Table 109. PTM BIO Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. PTM BIO Blood Proteomics Services Product Portfolio Table 111. PTM BIO Recent Development Table 112. BGI Genomics Company Information Table 113. BGI Genomics Business Overview Table 114. BGI Genomics Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. BGI Genomics Blood Proteomics Services Product Portfolio Table 116. BGI Genomics Recent Development Table 117. Evotec Company Information Table 118. Evotec Business Overview Table 119. Evotec Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Evotec Blood Proteomics Services Product Portfolio Table 121. Evotec Recent Development Table 122. Metware Biotechnology Company Information Table 123. Metware Biotechnology Business Overview Table 124. Metware Biotechnology Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Metware Biotechnology Blood Proteomics Services Product Portfolio Table 126. Metware Biotechnology Recent Development Table 127. MRM Proteomics Company Information Table 128. MRM Proteomics Business Overview Table 129. MRM Proteomics Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. MRM Proteomics Blood Proteomics Services Product Portfolio Table 131. MRM Proteomics Recent Development Table 132. Lc-Bio Technologies Company Information Table 133. Lc-Bio Technologies Business Overview Table 134. Lc-Bio Technologies Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Lc-Bio Technologies Blood Proteomics Services Product Portfolio Table 136. Lc-Bio Technologies Recent Development Table 137. Eurofins Scientific Company Information Table 138. Eurofins Scientific Business Overview Table 139. Eurofins Scientific Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Eurofins Scientific Blood Proteomics Services Product Portfolio Table 141. Eurofins Scientific Recent Development Table 142. MtoZ-Biolabs Company Information Table 143. MtoZ-Biolabs Business Overview Table 144. MtoZ-Biolabs Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. MtoZ-Biolabs Blood Proteomics Services Product Portfolio Table 146. MtoZ-Biolabs Recent Development Table 147. Creative Proteomics Company Information Table 148. Creative Proteomics Business Overview Table 149. Creative Proteomics Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Creative Proteomics Blood Proteomics Services Product Portfolio Table 151. Creative Proteomics Recent Development Table 152. Macrogen Company Information Table 153. Macrogen Business Overview Table 154. Macrogen Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Macrogen Blood Proteomics Services Product Portfolio Table 156. Macrogen Recent Development Table 157. TATAA Biocenter Company Information Table 158. TATAA Biocenter Business Overview Table 159. TATAA Biocenter Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. TATAA Biocenter Blood Proteomics Services Product Portfolio Table 161. TATAA Biocenter Recent Development Table 162. OmicScouts (Momentum Biotechnologies) Company Information Table 163. OmicScouts (Momentum Biotechnologies) Business Overview Table 164. OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Product Portfolio Table 166. OmicScouts (Momentum Biotechnologies) Recent Development Table 167. Precision Biomarker Laboratories (PBL) Company Information Table 168. Precision Biomarker Laboratories (PBL) Business Overview Table 169. Precision Biomarker Laboratories (PBL) Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. Precision Biomarker Laboratories (PBL) Blood Proteomics Services Product Portfolio Table 171. Precision Biomarker Laboratories (PBL) Recent Development Table 172. Shanghai OE Biotech Company Information Table 173. Shanghai OE Biotech Business Overview Table 174. Shanghai OE Biotech Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 175. Shanghai OE Biotech Blood Proteomics Services Product Portfolio Table 176. Shanghai OE Biotech Recent Development Table 177. RxCelerate Company Information Table 178. RxCelerate Business Overview Table 179. RxCelerate Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 180. RxCelerate Blood Proteomics Services Product Portfolio Table 181. RxCelerate Recent Development Table 182. Proteomics International Company Information Table 183. Proteomics International Business Overview Table 184. Proteomics International Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 185. Proteomics International Blood Proteomics Services Product Portfolio Table 186. Proteomics International Recent Development Table 187. Proteome Sciences Company Information Table 188. Proteome Sciences Business Overview Table 189. Proteome Sciences Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 190. Proteome Sciences Blood Proteomics Services Product Portfolio Table 191. Proteome Sciences Recent Development Table 192. Westlake Omics Company Information Table 193. Westlake Omics Business Overview Table 194. Westlake Omics Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 195. Westlake Omics Blood Proteomics Services Product Portfolio Table 196. Westlake Omics Recent Development Table 197. Crown Bioscience Company Information Table 198. Crown Bioscience Business Overview Table 199. Crown Bioscience Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 200. Crown Bioscience Blood Proteomics Services Product Portfolio Table 201. Crown Bioscience Recent Development Table 202. VProteomics Company Information Table 203. VProteomics Business Overview Table 204. VProteomics Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 205. VProteomics Blood Proteomics Services Product Portfolio Table 206. VProteomics Recent Development Table 207. Shanghai Majorbio Bio-Pharm Company Information Table 208. Shanghai Majorbio Bio-Pharm Business Overview Table 209. Shanghai Majorbio Bio-Pharm Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 210. Shanghai Majorbio Bio-Pharm Blood Proteomics Services Product Portfolio Table 211. Shanghai Majorbio Bio-Pharm Recent Development Table 212. Applied Biomics Company Information Table 213. Applied Biomics Business Overview Table 214. Applied Biomics Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 215. Applied Biomics Blood Proteomics Services Product Portfolio Table 216. Applied Biomics Recent Development Table 217. Sapient Bioanalytics Company Information Table 218. Sapient Bioanalytics Business Overview Table 219. Sapient Bioanalytics Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 220. Sapient Bioanalytics Blood Proteomics Services Product Portfolio Table 221. Sapient Bioanalytics Recent Development Table 222. Allumiqs Company Information Table 223. Allumiqs Business Overview Table 224. Allumiqs Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 225. Allumiqs Blood Proteomics Services Product Portfolio Table 226. Allumiqs Recent Development Table 227. MS Bioworks Company Information Table 228. MS Bioworks Business Overview Table 229. MS Bioworks Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 230. MS Bioworks Blood Proteomics Services Product Portfolio Table 231. MS Bioworks Recent Development Table 232. Shanghai Bioprofile Company Information Table 233. Shanghai Bioprofile Business Overview Table 234. Shanghai Bioprofile Blood Proteomics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 235. Shanghai Bioprofile Blood Proteomics Services Product Portfolio Table 236. Shanghai Bioprofile Recent Development Table 237. North America Blood Proteomics Services Revenue by Type (2021-2026) & (US$ Million) Table 238. North America Blood Proteomics Services Revenue by Type (2027-2032) & (US$ Million) Table 239. North America Blood Proteomics Services Revenue by Application (2021-2026) & (US$ Million) Table 240. North America Blood Proteomics Services Revenue by Application (2027-2032) & (US$ Million) Table 241. North America Blood Proteomics Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 242. North America Blood Proteomics Services Revenue by Country (2021-2026) & (US$ Million) Table 243. North America Blood Proteomics Services Revenue by Country (US$ Million) & (2027-2032) Table 244. Europe Blood Proteomics Services Revenue by Type (2021-2026) & (US$ Million) Table 245. Europe Blood Proteomics Services Revenue by Type (2027-2032) & (US$ Million) Table 246. Europe Blood Proteomics Services Revenue by Application (2021-2026) & (US$ Million) Table 247. Europe Blood Proteomics Services Revenue by Application (2027-2032) & (US$ Million) Table 248. Europe Blood Proteomics Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 249. Europe Blood Proteomics Services Revenue by Country (2021-2026) & (US$ Million) Table 250. Europe Blood Proteomics Services Revenue by Country (US$ Million) & (2027-2032) Table 251. China Blood Proteomics Services Revenue by Type (2021-2026) & (US$ Million) Table 252. China Blood Proteomics Services Revenue by Type (2027-2032) & (US$ Million) Table 253. China Blood Proteomics Services Revenue by Application (2021-2026) & (US$ Million) Table 254. China Blood Proteomics Services Revenue by Application (2027-2032) & (US$ Million) Table 255. Asia Blood Proteomics Services Revenue by Type (2021-2026) & (US$ Million) Table 256. Asia Blood Proteomics Services Revenue by Type (2027-2032) & (US$ Million) Table 257. Asia Blood Proteomics Services Revenue by Application (2021-2026) & (US$ Million) Table 258. Asia Blood Proteomics Services Revenue by Application (2027-2032) & (US$ Million) Table 259. Asia Blood Proteomics Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 260. Asia Blood Proteomics Services Revenue by Region (US$ Million) & (2021-2026) Table 261. Asia Blood Proteomics Services Revenue by Region (US$ Million) & (2027-2032) Table 262. SAMEA Blood Proteomics Services Revenue by Type (2021-2026) & (US$ Million) Table 263. SAMEA Blood Proteomics Services Revenue by Type (2027-2032) & (US$ Million) Table 264. SAMEA Blood Proteomics Services Revenue by Application (2021-2026) & (US$ Million) Table 265. SAMEA Blood Proteomics Services Revenue by Application (2027-2032) & (US$ Million) Table 266. SAMEA Blood Proteomics Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 267. SAMEA Blood Proteomics Services Revenue by Country (2021-2026) & (US$ Million) Table 268. SAMEA Blood Proteomics Services Revenue by Country (US$ Million) & (2027-2032) Table 269. Research Programs/Design for This Report Table 270. Authors List of This Report Table 271. Secondary Sources Table 272. Primary Sources List of Figures Figure 1. Blood Proteomics Services Image Figure 2. Global Blood Proteomics Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Proteomics Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Blood Proteomics Image Figure 5. Blood Modification Proteomics Image Figure 6. Olink (Targeted) Proteomics Image Figure 7. Global Blood Proteomics Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Blood Proteomics Services Market Size Share 2021 VS 2025 VS 2032 Figure 9. Disease Biomarker Research Image Figure 10. Drug Development Image Figure 11. Clinical Research Image Figure 12. Others Image Figure 13. Global Blood Proteomics Services Market Size (US$ Million) & (2021-2032) Figure 14. Global Blood Proteomics Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Blood Proteomics Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Blood Proteomics Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Blood Proteomics Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Blood Proteomics Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Blood Proteomics Services Revenue Market Share by Type (2021-2032) Figure 21. Global Blood Proteomics Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Blood Proteomics Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Blood Proteomics Services Revenue Market Share by Application (2021-2032) Figure 24. North America Blood Proteomics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Blood Proteomics Services Revenue Share by Type (2021-2032) Figure 26. North America Blood Proteomics Services Revenue Share by Application (2021-2032) Figure 27. North America Blood Proteomics Services Revenue Share by Country (2021-2032) Figure 28. United States Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Blood Proteomics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Blood Proteomics Services Revenue Share by Type (2021-2032) Figure 33. Europe Blood Proteomics Services Revenue Share by Application (2021-2032) Figure 34. Europe Blood Proteomics Services Revenue Share by Country (2021-2032) Figure 35. Germany Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Blood Proteomics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Blood Proteomics Services Revenue Share by Type (2021-2032) Figure 45. China Blood Proteomics Services Revenue Share by Application (2021-2032) Figure 46. Asia Blood Proteomics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Blood Proteomics Services Revenue Share by Type (2021-2032) Figure 48. Asia Blood Proteomics Services Revenue Share by Application (2021-2032) Figure 49. Asia Blood Proteomics Services Revenue Share by Region (2021-2032) Figure 50. Japan Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Blood Proteomics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Blood Proteomics Services Revenue Share by Type (2021-2032) Figure 58. SAMEA Blood Proteomics Services Revenue Share by Application (2021-2032) Figure 59. SAMEA Blood Proteomics Services Revenue Share by Country (2021-2032) Figure 60. Brazil Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Blood Proteomics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Proteomics
  • Blood Modification Proteomics
  • Olink (Targeted) Proteomics
Applications
  • Disease Biomarker Research
  • Drug Development
  • Clinical Research
  • Others
Companies covered
  • BostonGene
  • CellCarta
  • GENEWIZ (Azenta Life Sciences)
  • CDI Labs
  • Biognosys
  • Discovery Life Sciences
  • Firalis Molecular Precision
  • Cell Signaling Technology (CST)
  • Sampled (Infinity Biologix)
  • APTBIO
  • Sinotech Genomics
  • Biodesix
  • Panome Bio
  • Novogene
  • PTM BIO
  • BGI Genomics
  • Evotec
  • Metware Biotechnology
  • MRM Proteomics
  • Lc-Bio Technologies
  • Eurofins Scientific
  • MtoZ-Biolabs
  • Creative Proteomics
  • Macrogen
  • TATAA Biocenter
  • OmicScouts (Momentum Biotechnologies)
  • Precision Biomarker Laboratories (PBL)
  • Shanghai OE Biotech
  • RxCelerate
  • Proteomics International
  • Proteome Sciences
  • Westlake Omics
  • Crown Bioscience
  • VProteomics
  • Shanghai Majorbio Bio-Pharm
  • Applied Biomics
  • Sapient Bioanalytics
  • Allumiqs
  • MS Bioworks
  • Shanghai Bioprofile
  • Cosmos Wisdom
  • Olink (Thermo Fisher Scientific)
  • SomaLogic (Illumina)
  • Labcorp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Blood Proteomics Services Market by Type
  3. 1.2.1 Global Blood Proteomics Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Blood Proteomics
  5. 1.2.3 Blood Modification Proteomics
  6. 1.2.4 Olink (Targeted) Proteomics
  7. 1.3 Blood Proteomics Services Market by Application
  8. 1.3.1 Global Blood Proteomics Services Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Disease Biomarker Research
  10. 1.3.3 Drug Development
  11. 1.3.4 Clinical Research
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Blood Proteomics Services Market Dynamics
  1. 2.1 Blood Proteomics Services Industry Trends
  2. 2.2 Blood Proteomics Services Industry Drivers
  3. 2.3 Blood Proteomics Services Industry Opportunities and Challenges
  4. 2.4 Blood Proteomics Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Blood Proteomics Services Market Perspective (2021-2032)
  2. 3.2 Global Blood Proteomics Services Growth Trends by Region
  3. 3.2.1 Global Blood Proteomics Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Blood Proteomics Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Blood Proteomics Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Blood Proteomics Services Revenue by Players
  2. 4.1.1 Global Blood Proteomics Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Blood Proteomics Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Blood Proteomics Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Blood Proteomics Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Blood Proteomics Services Key Players Headquarters & Area Served
  7. 4.4 Global Blood Proteomics Services Players, Product Type & Application
  8. 4.5 Global Blood Proteomics Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Blood Proteomics Services Market CR5 and HHI
  11. 4.6.3 2025 Blood Proteomics Services Tier 1, Tier 2, and Tier 3
5 Blood Proteomics Services Market Size by Type
  1. 5.1 Global Blood Proteomics Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Blood Proteomics Services Revenue by Type (2021-2032)
  3. 5.3 Global Blood Proteomics Services Revenue Market Share by Type (2021-2032)
6 Blood Proteomics Services Market Size by Application
  1. 6.1 Global Blood Proteomics Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Blood Proteomics Services Revenue by Application (2021-2032)
  3. 6.3 Global Blood Proteomics Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 BostonGene
  2. 7.1.1 BostonGene Company Information
  3. 7.1.2 BostonGene Business Overview
  4. 7.1.3 BostonGene Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 BostonGene Blood Proteomics Services Product Portfolio
  6. 7.1.5 BostonGene Recent Developments
  7. 7.2 CellCarta
  8. 7.2.1 CellCarta Company Information
  9. 7.2.2 CellCarta Business Overview
  10. 7.2.3 CellCarta Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 CellCarta Blood Proteomics Services Product Portfolio
  12. 7.2.5 CellCarta Recent Developments
  13. 7.3 GENEWIZ (Azenta Life Sciences)
  14. 7.3.1 GENEWIZ (Azenta Life Sciences) Company Information
  15. 7.3.2 GENEWIZ (Azenta Life Sciences) Business Overview
  16. 7.3.3 GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Product Portfolio
  18. 7.3.5 GENEWIZ (Azenta Life Sciences) Recent Developments
  19. 7.4 CDI Labs
  20. 7.4.1 CDI Labs Company Information
  21. 7.4.2 CDI Labs Business Overview
  22. 7.4.3 CDI Labs Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 CDI Labs Blood Proteomics Services Product Portfolio
  24. 7.4.5 CDI Labs Recent Developments
  25. 7.5 Biognosys
  26. 7.5.1 Biognosys Company Information
  27. 7.5.2 Biognosys Business Overview
  28. 7.5.3 Biognosys Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Biognosys Blood Proteomics Services Product Portfolio
  30. 7.5.5 Biognosys Recent Developments
  31. 7.6 Discovery Life Sciences
  32. 7.6.1 Discovery Life Sciences Company Information
  33. 7.6.2 Discovery Life Sciences Business Overview
  34. 7.6.3 Discovery Life Sciences Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Discovery Life Sciences Blood Proteomics Services Product Portfolio
  36. 7.6.5 Discovery Life Sciences Recent Developments
  37. 7.7 Firalis Molecular Precision
  38. 7.7.1 Firalis Molecular Precision Company Information
  39. 7.7.2 Firalis Molecular Precision Business Overview
  40. 7.7.3 Firalis Molecular Precision Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Firalis Molecular Precision Blood Proteomics Services Product Portfolio
  42. 7.7.5 Firalis Molecular Precision Recent Developments
  43. 7.8 Cell Signaling Technology (CST)
  44. 7.8.1 Cell Signaling Technology (CST) Company Information
  45. 7.8.2 Cell Signaling Technology (CST) Business Overview
  46. 7.8.3 Cell Signaling Technology (CST) Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Cell Signaling Technology (CST) Blood Proteomics Services Product Portfolio
  48. 7.8.5 Cell Signaling Technology (CST) Recent Developments
  49. 7.9 Sampled (Infinity Biologix)
  50. 7.9.1 Sampled (Infinity Biologix) Company Information
  51. 7.9.2 Sampled (Infinity Biologix) Business Overview
  52. 7.9.3 Sampled (Infinity Biologix) Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sampled (Infinity Biologix) Blood Proteomics Services Product Portfolio
  54. 7.9.5 Sampled (Infinity Biologix) Recent Developments
  55. 7.10 APTBIO
  56. 7.10.1 APTBIO Company Information
  57. 7.10.2 APTBIO Business Overview
  58. 7.10.3 APTBIO Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 APTBIO Blood Proteomics Services Product Portfolio
  60. 7.10.5 APTBIO Recent Developments
  61. 7.11 Sinotech Genomics
  62. 7.11.1 Sinotech Genomics Company Information
  63. 7.11.2 Sinotech Genomics Business Overview
  64. 7.11.3 Sinotech Genomics Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Sinotech Genomics Blood Proteomics Services Product Portfolio
  66. 7.11.5 Sinotech Genomics Recent Developments
  67. 7.12 Biodesix
  68. 7.12.1 Biodesix Company Information
  69. 7.12.2 Biodesix Business Overview
  70. 7.12.3 Biodesix Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Biodesix Blood Proteomics Services Product Portfolio
  72. 7.12.5 Biodesix Recent Developments
  73. 7.13 Panome Bio
  74. 7.13.1 Panome Bio Company Information
  75. 7.13.2 Panome Bio Business Overview
  76. 7.13.3 Panome Bio Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Panome Bio Blood Proteomics Services Product Portfolio
  78. 7.13.5 Panome Bio Recent Developments
  79. 7.14 Novogene
  80. 7.14.1 Novogene Company Information
  81. 7.14.2 Novogene Business Overview
  82. 7.14.3 Novogene Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Novogene Blood Proteomics Services Product Portfolio
  84. 7.14.5 Novogene Recent Developments
  85. 7.15 PTM BIO
  86. 7.15.1 PTM BIO Company Information
  87. 7.15.2 PTM BIO Business Overview
  88. 7.15.3 PTM BIO Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 PTM BIO Blood Proteomics Services Product Portfolio
  90. 7.15.5 PTM BIO Recent Developments
  91. 7.16 BGI Genomics
  92. 7.16.1 BGI Genomics Company Information
  93. 7.16.2 BGI Genomics Business Overview
  94. 7.16.3 BGI Genomics Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 BGI Genomics Blood Proteomics Services Product Portfolio
  96. 7.16.5 BGI Genomics Recent Developments
  97. 7.17 Evotec
  98. 7.17.1 Evotec Company Information
  99. 7.17.2 Evotec Business Overview
  100. 7.17.3 Evotec Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Evotec Blood Proteomics Services Product Portfolio
  102. 7.17.5 Evotec Recent Developments
  103. 7.18 Metware Biotechnology
  104. 7.18.1 Metware Biotechnology Company Information
  105. 7.18.2 Metware Biotechnology Business Overview
  106. 7.18.3 Metware Biotechnology Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Metware Biotechnology Blood Proteomics Services Product Portfolio
  108. 7.18.5 Metware Biotechnology Recent Developments
  109. 7.19 MRM Proteomics
  110. 7.19.1 MRM Proteomics Company Information
  111. 7.19.2 MRM Proteomics Business Overview
  112. 7.19.3 MRM Proteomics Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  113. 7.19.4 MRM Proteomics Blood Proteomics Services Product Portfolio
  114. 7.19.5 MRM Proteomics Recent Developments
  115. 7.20 Lc-Bio Technologies
  116. 7.20.1 Lc-Bio Technologies Company Information
  117. 7.20.2 Lc-Bio Technologies Business Overview
  118. 7.20.3 Lc-Bio Technologies Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Lc-Bio Technologies Blood Proteomics Services Product Portfolio
  120. 7.20.5 Lc-Bio Technologies Recent Developments
  121. 7.21 Eurofins Scientific
  122. 7.21.1 Eurofins Scientific Company Information
  123. 7.21.2 Eurofins Scientific Business Overview
  124. 7.21.3 Eurofins Scientific Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Eurofins Scientific Blood Proteomics Services Product Portfolio
  126. 7.21.5 Eurofins Scientific Recent Developments
  127. 7.22 MtoZ-Biolabs
  128. 7.22.1 MtoZ-Biolabs Company Information
  129. 7.22.2 MtoZ-Biolabs Business Overview
  130. 7.22.3 MtoZ-Biolabs Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  131. 7.22.4 MtoZ-Biolabs Blood Proteomics Services Product Portfolio
  132. 7.22.5 MtoZ-Biolabs Recent Developments
  133. 7.23 Creative Proteomics
  134. 7.23.1 Creative Proteomics Company Information
  135. 7.23.2 Creative Proteomics Business Overview
  136. 7.23.3 Creative Proteomics Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Creative Proteomics Blood Proteomics Services Product Portfolio
  138. 7.23.5 Creative Proteomics Recent Developments
  139. 7.24 Macrogen
  140. 7.24.1 Macrogen Company Information
  141. 7.24.2 Macrogen Business Overview
  142. 7.24.3 Macrogen Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Macrogen Blood Proteomics Services Product Portfolio
  144. 7.24.5 Macrogen Recent Developments
  145. 7.25 TATAA Biocenter
  146. 7.25.1 TATAA Biocenter Company Information
  147. 7.25.2 TATAA Biocenter Business Overview
  148. 7.25.3 TATAA Biocenter Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  149. 7.25.4 TATAA Biocenter Blood Proteomics Services Product Portfolio
  150. 7.25.5 TATAA Biocenter Recent Developments
  151. 7.26 OmicScouts (Momentum Biotechnologies)
  152. 7.26.1 OmicScouts (Momentum Biotechnologies) Company Information
  153. 7.26.2 OmicScouts (Momentum Biotechnologies) Business Overview
  154. 7.26.3 OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  155. 7.26.4 OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Product Portfolio
  156. 7.26.5 OmicScouts (Momentum Biotechnologies) Recent Developments
  157. 7.27 Precision Biomarker Laboratories (PBL)
  158. 7.27.1 Precision Biomarker Laboratories (PBL) Company Information
  159. 7.27.2 Precision Biomarker Laboratories (PBL) Business Overview
  160. 7.27.3 Precision Biomarker Laboratories (PBL) Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Precision Biomarker Laboratories (PBL) Blood Proteomics Services Product Portfolio
  162. 7.27.5 Precision Biomarker Laboratories (PBL) Recent Developments
  163. 7.28 Shanghai OE Biotech
  164. 7.28.1 Shanghai OE Biotech Company Information
  165. 7.28.2 Shanghai OE Biotech Business Overview
  166. 7.28.3 Shanghai OE Biotech Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  167. 7.28.4 Shanghai OE Biotech Blood Proteomics Services Product Portfolio
  168. 7.28.5 Shanghai OE Biotech Recent Developments
  169. 7.29 RxCelerate
  170. 7.29.1 RxCelerate Company Information
  171. 7.29.2 RxCelerate Business Overview
  172. 7.29.3 RxCelerate Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  173. 7.29.4 RxCelerate Blood Proteomics Services Product Portfolio
  174. 7.29.5 RxCelerate Recent Developments
  175. 7.30 Proteomics International
  176. 7.30.1 Proteomics International Company Information
  177. 7.30.2 Proteomics International Business Overview
  178. 7.30.3 Proteomics International Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  179. 7.30.4 Proteomics International Blood Proteomics Services Product Portfolio
  180. 7.30.5 Proteomics International Recent Developments
  181. 7.31 Proteome Sciences
  182. 7.31.1 Proteome Sciences Company Information
  183. 7.31.2 Proteome Sciences Business Overview
  184. 7.31.3 Proteome Sciences Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  185. 7.31.4 Proteome Sciences Blood Proteomics Services Product Portfolio
  186. 7.31.5 Proteome Sciences Recent Developments
  187. 7.32 Westlake Omics
  188. 7.32.1 Westlake Omics Company Information
  189. 7.32.2 Westlake Omics Business Overview
  190. 7.32.3 Westlake Omics Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  191. 7.32.4 Westlake Omics Blood Proteomics Services Product Portfolio
  192. 7.32.5 Westlake Omics Recent Developments
  193. 7.33 Crown Bioscience
  194. 7.33.1 Crown Bioscience Company Information
  195. 7.33.2 Crown Bioscience Business Overview
  196. 7.33.3 Crown Bioscience Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  197. 7.33.4 Crown Bioscience Blood Proteomics Services Product Portfolio
  198. 7.33.5 Crown Bioscience Recent Developments
  199. 7.34 VProteomics
  200. 7.34.1 VProteomics Company Information
  201. 7.34.2 VProteomics Business Overview
  202. 7.34.3 VProteomics Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  203. 7.34.4 VProteomics Blood Proteomics Services Product Portfolio
  204. 7.34.5 VProteomics Recent Developments
  205. 7.35 Shanghai Majorbio Bio-Pharm
  206. 7.35.1 Shanghai Majorbio Bio-Pharm Company Information
  207. 7.35.2 Shanghai Majorbio Bio-Pharm Business Overview
  208. 7.35.3 Shanghai Majorbio Bio-Pharm Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  209. 7.35.4 Shanghai Majorbio Bio-Pharm Blood Proteomics Services Product Portfolio
  210. 7.35.5 Shanghai Majorbio Bio-Pharm Recent Developments
  211. 7.36 Applied Biomics
  212. 7.36.1 Applied Biomics Company Information
  213. 7.36.2 Applied Biomics Business Overview
  214. 7.36.3 Applied Biomics Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  215. 7.36.4 Applied Biomics Blood Proteomics Services Product Portfolio
  216. 7.36.5 Applied Biomics Recent Developments
  217. 7.37 Sapient Bioanalytics
  218. 7.37.1 Sapient Bioanalytics Company Information
  219. 7.37.2 Sapient Bioanalytics Business Overview
  220. 7.37.3 Sapient Bioanalytics Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  221. 7.37.4 Sapient Bioanalytics Blood Proteomics Services Product Portfolio
  222. 7.37.5 Sapient Bioanalytics Recent Developments
  223. 7.38 Allumiqs
  224. 7.38.1 Allumiqs Company Information
  225. 7.38.2 Allumiqs Business Overview
  226. 7.38.3 Allumiqs Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  227. 7.38.4 Allumiqs Blood Proteomics Services Product Portfolio
  228. 7.38.5 Allumiqs Recent Developments
  229. 7.39 MS Bioworks
  230. 7.39.1 MS Bioworks Company Information
  231. 7.39.2 MS Bioworks Business Overview
  232. 7.39.3 MS Bioworks Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  233. 7.39.4 MS Bioworks Blood Proteomics Services Product Portfolio
  234. 7.39.5 MS Bioworks Recent Developments
  235. 7.40 Shanghai Bioprofile
  236. 7.40.1 Shanghai Bioprofile Company Information
  237. 7.40.2 Shanghai Bioprofile Business Overview
  238. 7.40.3 Shanghai Bioprofile Blood Proteomics Services Revenue and Gross Margin (2021-2026)
  239. 7.40.4 Shanghai Bioprofile Blood Proteomics Services Product Portfolio
  240. 7.40.5 Shanghai Bioprofile Recent Developments
  241. 7.41 Cosmos Wisdom
  242. 7.42 Olink (Thermo Fisher Scientific)
  243. 7.43 SomaLogic (Illumina)
  244. 7.44 Labcorp
8 North America
  1. 8.1 North America Blood Proteomics Services Revenue (2021-2032)
  2. 8.2 North America Blood Proteomics Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Blood Proteomics Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Blood Proteomics Services Revenue by Type (2027-2032)
  5. 8.3 North America Blood Proteomics Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Blood Proteomics Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Blood Proteomics Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Blood Proteomics Services Revenue by Application (2027-2032)
  9. 8.5 North America Blood Proteomics Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Blood Proteomics Services Revenue by Country
  11. 8.6.1 North America Blood Proteomics Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Blood Proteomics Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Blood Proteomics Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Blood Proteomics Services Revenue (2021-2032)
  2. 9.2 Europe Blood Proteomics Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Blood Proteomics Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Blood Proteomics Services Revenue by Type (2027-2032)
  5. 9.3 Europe Blood Proteomics Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Blood Proteomics Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Blood Proteomics Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Blood Proteomics Services Revenue by Application (2027-2032)
  9. 9.5 Europe Blood Proteomics Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Blood Proteomics Services Revenue by Country
  11. 9.6.1 Europe Blood Proteomics Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Blood Proteomics Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Blood Proteomics Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Blood Proteomics Services Revenue (2021-2032)
  2. 10.2 China Blood Proteomics Services Revenue by Type (2021-2032)
  3. 10.2.1 China Blood Proteomics Services Revenue by Type (2021-2026)
  4. 10.2.2 China Blood Proteomics Services Revenue by Type (2027-2032)
  5. 10.3 China Blood Proteomics Services Revenue Share by Type (2021-2032)
  6. 10.4 China Blood Proteomics Services Revenue by Application (2021-2032)
  7. 10.4.1 China Blood Proteomics Services Revenue by Application (2021-2026)
  8. 10.4.2 China Blood Proteomics Services Revenue by Application (2027-2032)
  9. 10.5 China Blood Proteomics Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Blood Proteomics Services Revenue (2021-2032)
  2. 11.2 Asia Blood Proteomics Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Blood Proteomics Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Blood Proteomics Services Revenue by Type (2027-2032)
  5. 11.3 Asia Blood Proteomics Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Blood Proteomics Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Blood Proteomics Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Blood Proteomics Services Revenue by Application (2027-2032)
  9. 11.5 Asia Blood Proteomics Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Blood Proteomics Services Revenue by Country
  11. 11.6.1 Asia Blood Proteomics Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Blood Proteomics Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Blood Proteomics Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Blood Proteomics Services Revenue (2021-2032)
  2. 12.2 SAMEA Blood Proteomics Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Blood Proteomics Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Blood Proteomics Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Blood Proteomics Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Blood Proteomics Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Blood Proteomics Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Blood Proteomics Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Blood Proteomics Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Blood Proteomics Services Revenue by Country
  11. 12.6.1 SAMEA Blood Proteomics Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Blood Proteomics Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Blood Proteomics Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst